Published Aug 7, 2023

Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast

Andrew Huberman delves into ketamine's transformative therapy potential, discussing its fast-acting benefits for depression and PTSD, neuroplasticity mechanisms involving BDNF, and the dissociative states that enhance its efficacy. The episode also examines the complexities of ketamine administration, emphasizing its various impacts depending on dosage and method.
Episode Highlights
Huberman Lab logo

Popular Clips

Questions from this episode

Episode Highlights

  • Dissociation

    Ketamine induces dissociative states, a phenomenon where individuals feel detached from their bodies, often observing themselves from a third-person perspective. This dissociation, while associated with PTSD and trauma, paradoxically provides relief from depression by altering brain circuits, particularly the neocortical regions 1. The uncoupling of these brain networks leads to a shift from alpha to theta brainwave patterns, creating a dreamlike state 1.

    When people take Ketamine, the alpha pattern of activity is completely abolished, at least for the duration of time that they're under the influence of the drug.

    ---

    Understanding the concept of "K-holes" is crucial, as it describes the pseudo-anesthetized state induced by high doses of ketamine, which can be dangerous, especially when combined with other substances 2.

       

    Antidepressant Effects

    The dissociative effects of ketamine contribute significantly to its antidepressant properties. While the subjective experiences during ketamine use are profound, the relief from depression may not solely stem from these experiences but rather from complex neuroplastic changes and opioid receptor interactions 3. Ketamine's dual action on the glutamate and opioid systems is pivotal, with its metabolite, hydroxy nor ketamine, specifically targeting opioid receptors, suggesting a major role in depression relief 4.

    When a human being takes ketamine in order to treat their depression and they get some relief from depression, is that the consequence of neuroplastic changes in all those NMDA Glutamate BDNF related circuits that we talked about before? Or is it the consequence of something happening in the Opioid system?

    ---

    Blocking the opioid receptors with naltrexone diminishes ketamine's antidepressant effects, highlighting the opioid system's importance in this therapeutic process 4.

Related Episodes